Total Payments
$2,634
2024 Payments
$523.11
Companies
26
Transactions
59
Medicare Patients
2,565
Medicare Billing
$369,251
Payment Breakdown by Category
Food & Beverage$2,597 (98.6%)
Education$36.24 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,597 | 56 | 98.6% |
| Education | $36.24 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | $332.35 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $245.13 | 3 | $0 (2024) |
| Amgen Inc. | $219.09 | 3 | $0 (2018) |
| Celgene Corporation | $208.24 | 2 | $0 (2020) |
| ABBVIE INC. | $154.65 | 8 | $0 (2024) |
| Genentech USA, Inc. | $152.77 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $145.97 | 2 | $0 (2020) |
| Janssen Biotech, Inc. | $144.36 | 5 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $129.16 | 1 | $0 (2017) |
| Puma Biotechnology, Inc. | $124.99 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $523.11 | 17 | ABBVIE INC. ($154.65) |
| 2023 | $483.05 | 11 | Myriad Genetic Laboratories, Inc. ($311.35) |
| 2022 | $34.99 | 2 | Myriad Genetic Laboratories, Inc. ($21.00) |
| 2021 | $90.38 | 6 | Pharmacyclics LLC, An AbbVie Company ($19.13) |
| 2020 | $349.34 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($117.29) |
| 2019 | $482.13 | 10 | Genentech USA, Inc. ($127.63) |
| 2018 | $440.11 | 6 | Puma Biotechnology, Inc. ($124.99) |
| 2017 | $230.60 | 3 | Janssen Scientific Affairs, LLC ($129.16) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Oncology | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/29/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: BioOncology | ||||||
| 06/22/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: ONCOLOGY | ||||||
| 06/21/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Oncology | ||||||
| 04/25/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $89.99 | General |
| Category: Oncology | ||||||
| 04/25/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $124.83 | General |
| Category: Oncology | ||||||
| 02/27/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/16/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Oncology | ||||||
| 01/24/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $142.56 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $113.13 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 557 | 1,169 | $267,896 | $76,553 |
| 2022 | 6 | 472 | 942 | $229,714 | $66,413 |
| 2021 | 7 | 688 | 1,349 | $419,696 | $110,629 |
| 2020 | 9 | 848 | 1,700 | $516,509 | $115,656 |
Total Patients
2,565
Total Services
5,160
Medicare Billing
$369,251
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 292 | 620 | $143,768 | $40,946 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 187 | $39,644 | $11,222 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 76 | $24,776 | $8,101 | 32.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 44 | 44 | $21,780 | $5,004 | 23.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 92 | $8,740 | $3,549 | 40.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 34 | $10,404 | $2,958 | 28.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 30 | 54 | $6,210 | $2,014 | 32.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 25 | 25 | $7,450 | $1,584 | 21.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,422 | $1,020 | 23.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 26 | $702.00 | $155.25 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 290 | 610 | $141,740 | $40,685 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 92 | 170 | $55,674 | $17,506 | 31.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 41 | $12,546 | $3,226 | 25.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 56 | $11,872 | $3,037 | 25.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 16 | $6,432 | $1,642 | 25.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 22 | 49 | $1,450 | $317.34 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 319 | 652 | $166,475 | $46,867 | 28.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 101 | 234 | $76,581 | $25,241 | 33.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 81 | 244 | $67,342 | $13,691 | 20.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 62 | 68 | $52,294 | $10,293 | 19.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 61 | 61 | $27,288 | $8,467 | 31.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 31 | 56 | $21,816 | $4,459 | 20.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 34 | $7,900 | $1,611 | 20.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 326 | 615 | $162,360 | $36,332 | 22.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 121 | 322 | $104,972 | $27,617 | 26.3% |
About Dr. Michael Ashigbi, M.D
Dr. Michael Ashigbi, M.D is a Hematology & Oncology healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649275355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ashigbi, M.D has received a total of $2,634 in payments from pharmaceutical and medical device companies, with $523.11 received in 2024. These payments were reported across 59 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,597).
As a Medicare-enrolled provider, Ashigbi has provided services to 2,565 Medicare beneficiaries, totaling 5,160 services with total Medicare billing of $369,251. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Tyler, TX
- Active Since 06/17/2005
- Last Updated 10/20/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1649275355
Products in Payments
- MYRISK (Device) $311.35
- EPKINLY (Drug) $252.49
- DARZALEX (Biological) $244.97
- Revlimid (Drug) $208.24
- TECENTRIQ (Biological) $127.63
- Nerlynx (Drug) $124.99
- IMFINZI (Biological) $124.83
- NINLARO (Drug) $117.29
- Enhertu (Drug) $113.09
- KEYTRUDA (Biological) $110.89
- CALQUENCE (Drug) $106.31
- Kyprolis (Biological) $99.00
- Vectibix (Biological) $97.42
- Onivyde (Drug) $71.01
- KISQALI (Drug) $52.85
- Cabometyx (Drug) $42.42
- Zydelig (Drug) $38.67
- PROMACTA (Drug) $26.32
- Tecentriq (Biological) $25.14
- LUTATHERA (Drug) $24.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Tyler
Sarah Wang, M.d, M.D
Hematology & Oncology — Payments: $42,889
Hematology & Oncology $42,889
Dr. Joseph Martins, M.d, M.D
Hematology & Oncology — Payments: $27,398
Hematology & Oncology $27,398
Dr. Katrina Glover, M.d, M.D
Hematology & Oncology — Payments: $8,266
Hematology & Oncology $8,266
Marc Usrey, M.d, M.D
Hematology & Oncology — Payments: $3,533
Hematology & Oncology $3,533
Dr. Gary Gross, Md, MD
Hematology & Oncology — Payments: $2,930
Hematology & Oncology $2,930
Dr. Arielle Lee, Md, MD
Hematology & Oncology — Payments: $2,820
Hematology & Oncology $2,820